NHS Prescription Services produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 47) contains some useful information and advice on: The new NHS Profile ManagerRequest for feedback on the Drug TariffMYS system downtimeHow to avoid refer backsA reminder to submit FP34C claims on time To view current and previous
Read moreCommunity pharmacy representatives have attended a Government meeting about disruptions to the supply of Hormone Replacement Therapy (HRT) medicines. Following growing public concern about obtaining HRT drugs, Health and Social Care Secretary Sajid Javid convened a round table discussion with key stakeholders across the supply chain, including community pharmacy. Manufacturers and suppliers of a range
Read moreFollowing the Department of Health and Social Care’s (DHSC) announcement of three new Serious Shortage Protocols (SSPs) for Hormone Replacement Therapy (HRT) medicines, PSNC has created a briefing titled ‘HRT Serious Shortage Protocols (SSPs) FAQs‘ to help pharmacists understand the requirements of these SSPs. In addition, to support pharmacy teams, PSNC has also put together some helpful
Read morePSNC Chief Executive Janet Morrison has recorded a video message for community pharmacy contractors about her personal reflections on the proposals for the future of PSNC and LPCs made by the Pharmacy Representation Review Steering Group (RSG). In the video, Janet recognises the proposals as sensible and practical steps that any modern and forward-thinking sector
Read moreContractors will have until the 7 June 2022 to submit their FP34C declaration through the Manage Your Service (MYS) portal for NHS pharmaceutical services delivered in May 2022. Normally, if one or more bank holiday occurs within the first five days of the month, contractors are given an extra day to complete their monthly submissions.
Read moreHealth Education England (HEE) are seeking the views of frontline community pharmacists to support the development of further training modules that support pharmacists in the provision of NHS community pharmacy services across England. HEE are working closely with NHS England and NHS Improvement to provide these training opportunities. Since 2019, the Centre for Pharmacy Postgraduate Education and the Royal Pharmaceutical
Read moreThe recently appointed Chief Pharmaceutical Officer (CPhO) for England, David Webb, delivered a keynote speech in person at the National Meeting of LPCs and PSNC on Thursday 17th May 2022. As the new head of the pharmacy professions, he set out his personal priorities for the next few years. At the start of his speech,
Read morePSNC has submitted its response to the proposals set out in the Department of Health and Social Care’s (DHSC’s) consultation on hub and spoke dispensing. The consultation proposes making legislative changes to allow the operation of hub and spoke dispensing across different legal entities, and proposes to introduce two different models for this. Model 1
Read moreAs part of recovery plans following COVID-19, the Royal College of General Practitioners (RCGP) has produced guidance for clinicians working in general practice, which sets out suggested actions for consideration to support long-term condition management over the next six months. Among the suggestions is for clinicians to consider signposting patients with cardiovascular disease to the
Read moreIn response to a significant ongoing disruption to the supply affecting Lipitor® 10mg chewable tablets and Paracetamol 120mg suppositories, two new Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care (DHSC). SSP 032 – Lipitor® 10mg chewable tablets Effective today, 31 May 2022, SSP032 provides that for every Lipitor® 10mg chewable tablet
Read more
